Healthcare | April 14, 2023
Max Healthcare Institute completes acquisition of further stake in Eqova Healthcare
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
The company had acquired 26,000 equity shares having face value of Rs. 10 each fully paid up of Eqova
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
With more than 35 years of experience, Best Formulations is the largest manufacturer of plant-based softgels in the United States, with newly expanded capabilities for nutritional gummies and personal care
To fund the upfront payment, Biocon Biologics has secured USD 1.2 billion of Sustainability Linked Loan
The acquisition reaffirms Infosys’ commitment to help global life sciences companies
AstraZeneca has acquired all outstanding equity of TeneoTwo in exchange for an upfront payment of $100m.
Biopharma and CROs to benefit from simplified access to global research sites
Subscribe To Our Newsletter & Stay Updated
